Climb Bio Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Climb Bio, Inc. (CLYM) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-73.90-35.12-45.24-47.48-20.67
Depreciation & Amortization0.000.000.000.370.00
Stock Based Compensation5.5612.816.993.740.71
Change in Working Capital1.703.760.72-6.74-2.94
Change in Accounts Payable-1.14-0.69-0.650.32-0.02
Change in Other Working Capital51.880.410.4411.72-2.91
Other Operating Activities51.880.416.3118.03-0.36
Net Cash from Operating Activities-15.56-20.60-37.37-36.07-14.10
Investing Activities
Acquisitions-4.650.000.000.008.28
Purchases of Investments-132.20-58.45-87.96-114.970.00
Sales/Maturities of Investments20.75127.4334.44-114.97-0.20
Other Investing Activities-9.650.000.000.000.00
Net Cash from Investing Activities-121.0968.9834.44-114.978.08
Financing Activities
Common Stock Issued119.750.840.000.150.00
Other Financing Activities-0.250.000.0083.140.00
Net Cash from Financing Activities130.730.840.00177.234.93
Summary
Effect of Forex Changes on Cash0.040.30-0.410.250.00
Net Change in Cash-5.9349.22-2.9326.44-0.74
Cash at Beginning of Period93.1143.5946.9220.490.00
Cash at End of Period87.2393.1143.5946.920.00
Free Cash Flow-15.56-20.60-37.37-36.070.00